What’s happening at UOHI, the Alumni as well as other heart related organizations
News & Events
We are about to start a program for comprehensive risk factor management and walking rehabilitation for patients with peripheral arterial disease / claudication, in order to better control their risk factors, decrease their future risk of cardiovascular events, and improve their walking abilities which will result in improvement in quality of life.read more
Guest Speaker: Chamoun Chamoun, MD, FRCPC
Topic: “Cardiac Tests and Medications”
CHICAGO, September 28, 2017 — Women with heart disease typically receive less complete surgical revascularization with arterial grafts than men do, but not because of gender bias. Instead, factors such as delayed diagnosis of coronary artery disease (CAD) in women may contribute to the differences in treatment, according to a new study published online today in The Annals of Thoracic Surgery.read more
Learn CPR with family and friends! This workshop is specifically designed for patients and family members of the University of Ottawa Heart Institute.read more
Don’t miss the 3rd Annual Capital Oktoberfest presented by MacKenzie Investments at Bier Markt Ottawa on October 4th in support of the University of Ottawa Heart Institute Foundation.read more
The Canadian Congenital Heart Alliance (CCHA) is thrilled to present a physical activity event series specifically designed for individuals living with congenital heart defects.read more
The Patient Alumni hosts many events throughout the year for its members including Meet the Expert Events, Healthy Food Workshops and our Annual General Meeting. To register for these events, simply follow the steps below.read more
We are proud to announce that just one year after our launch, over four thousand patients have been using the portal to access their health information!read more
Saturday, September 30th
St Luke’s Anglican Church, 760 Somerset St. West, Ottawa
The University of Ottawa Heart Institute (UOHI) and The Ottawa Hospital have recently launched a clinical trial (99mTc-rhAnnexin V-128 Imaging of Apoptosis and Cardiotoxicity in Relationship to Ventricular Function in Patients with Early Stage Breast Cancer Receiving Doxorubicin-Based Chemotherapy) to assess the use of a novel imaging test in breast cancer patients undergoing chemotherapy.read more
We thank Scotiabank for the generous contribution they made to the Institute as it moves towards the expansion of its patient care facilities.
Sign Up for my OttawaHeart
Get access to a secure online patient portal.
Join fellow alumni in conversations about heart, health and healing
A new place to share, support and gather.